GP
CPXX

GLG Partners’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

GLG Partners’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-159,041
Closed -$4.8M – 558
2016
Q2 		$4.8M Buy
+159,041
New +$3.23M 0.14% 194

GLG Partners's CPXX Position: Q3 2016 in Review

GLG Partners sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 159,041 shares — an estimated $4.8M sold.

GLG Partners first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $4.8M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • GLG Partners reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • GLG Partners sold 159,041 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $4.8M.
  • GLG Partners first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • GLG Partners's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $4.8M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on GLG Partners's 13F filing for Q3 2016, filed 14 Nov 2016.